Uveitis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are between 18 and 70 years old
- You have never had tuberculosis (TB) in the past, and do not currently have an active or dormant TB infection
- You have been diagnosed with Vogt-Koyanagi-Harada (VKH) disease for less than one month
- You have been treated with steroid tablets or injections (taken throughout the body, not just the eye) for less than one week
- You meet at least one of the following: you do not want to take long-term steroids because of the side effects; you have another health condition that makes taking steroids risky or unsuitable; or your retinal detachment has not improved much after one week of high-dose steroid treatment
Who may not be able to join:
- You have, or are suspected to have, an eye inflammation caused by an infection (such as TB, herpes, toxoplasmosis, Lyme disease, or several other infections)
- You have cloudiness in the cornea or lens of your eye that blocks a clear view of the back of your eye, or that is likely to need cataract surgery during the trial
- You have previously been treated with a type of medication called anti-TNF therapy or any similar biological drug used to treat eye inflammation
- You have received a specific steroid eye implant called Ozurdex® within the last 6 months
- You have received certain injections into the eye (anti-VEGF treatments such as Lucentis®, Avastin®, or Eylea®) within the last 45 to 60 days, depending on the specific medication
- You have received methotrexate injected into the eye within the last 90 days
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +86-13920023990
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change In LogMAR Best Corrected Visual Acuity (BCVA) From Baseline to Each Visit.; Recurrence rate
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.